Mission: Cure aims to demonstrate a new, faster model for curing diseases using innovative financing based on patient outcomes, starting with chronic pancreatitis. Chronic and recurrent acute pancreatitis is a devastating disease, and we are fighting for a cure. As a coalition of doctors, researchers, patients, and entrepreneurs, we are pioneering a new approach to curing this disease through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
Mission: Cure was founded in 2017 by Megan Golden, a leader in innovative, outcome-based financing and by Linda Martin, a veteran technology entrepreneur. Mission: Cure is pioneering a new funding model that creates new incentives for patient outcomes. We envision a world where...
- Patients will be able to prevent or treat their disease so they are no longer in pain and live longer, healthier, more productive lives.
- Scientists and Clinicians will have sufficient funding and support to pursue and succeed in their efforts to help patients and cure disease.
- Healthcare Payers will invest in new treatments that improve patient and employer outcomes and reduce costly crisis care and ineffective treatments.
- Healthcare Providers will have the time and resources (including data and multidisciplinary care) to work empathetically with each patient to accurately diagnose and treat their health conditions and optimize health outcomes and quality of life.
